MAPT and early-onset autosomal dominant Alzheimer disease: Plasma p-tau Thr181 concentrations are increased in Alzheimer's disease and strongly correlate with amyloid beta-PET-positivity and cortical tau protein deposition as judged by (18)F-flortaucipir PET [99].